MEDIA
Press Release
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea
Copyright 2021 - BIXINK │ Terms of Use
Contact │ Privacy
6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258,
Republic of Korea
6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea [06125]
Copyright 2021 - BIXINK │ Terms of Use │ Contact │ Privacy
6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea